PJ
Therapeutic Areas
180 Life Sciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Anti-TNF (Local Injection) | Dupuytren's Disease (Early Stage) | Phase 2b |
| Synthetic Cannabinoid Analogs | Undisclosed Inflammatory/Pain Indications | Preclinical |
Leadership Team at 180 Life Sciences
DJ
Dr. James N. Woody
Former CEO, Scientific Founder
PS
Prof. Sir Marc Feldmann
Scientific Founder and Advisor